Independence Blue Cross began limiting coverage of GLP-1 drugs on Jan. 1 to some medical conditions, but not obesity or weight loss.

Next-generation obesity drugs will work differently from Ozempic and Wegovy — aiming to deliver greater weight loss with ...

The heart drug digoxin could potentially be combined with existing cancer therapies to prevent the spread of tumors, an early ...

In the early hours of September 14, 2021, three men parked in a quiet car park in the southern English market town of ...

Indicates growing incidence of cancer among Indian population; five out of top 20 new brand launches are cancer drugs ...